<?xml version="1.0" encoding="utf-8" ?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Viviancreative - Latest News</title>
<link href="https://news.newswirebiz.com/rss/viviancreative/latest.xml"></link>
<updated>2026-07-20T10:49:20+00:00</updated>
<id>urn:uuid:ca598ede-3a66-4224-bdf7-624b59c1e435</id>
<entry>
<title>Creative Biolabs Showcases Exosome Engineering Strategies for Targeted Delivery of CRISPR/Cas System</title>
<link href="https://news.newswirebiz.com/@viviancreative/creative-biolabs-showcases-exosome-engineering-strategies-for-targeted-delivery-of-crispr-cas-system-qjo9ciy8sitg"></link>
<id>urn:uuid:c4be6fad-aa93-999d-192d-b9d42ccfd0d1</id>
<summary type="html"><![CDATA[The potential of exosomes as an alternative delivery vector for the CRISPR/Cas9 components encourages Creative Biolabs to present its exosome engineering strategies.]]></summary>
<updated>2023-06-27T01:34:19+00:00</updated>
</entry>
<entry>
<title>Creative Biolabs Catches Wind of Stem Cell-Derived Exosome Therapeutics in Stroke</title>
<link href="https://news.newswirebiz.com/@viviancreative/creative-biolabs-catches-wind-of-stem-cell-derived-exosome-therapeutics-in-stroke-jlrb7yysonlx"></link>
<id>urn:uuid:5434a62e-6b0c-c8b2-0fec-2959d62388d9</id>
<summary type="html"><![CDATA[Considering a recently featured article by NIH introducing the therapeutic effects of NSC-derived exosomes in cerebral ischemia, Creative Biolabs updates its service portfolio related to stem cell-derived exosomes.]]></summary>
<updated>2023-06-15T03:35:41+00:00</updated>
</entry>
<entry>
<title>Creative Biolabs Participates in Booming Exosome Manufacturing Market Growth</title>
<link href="https://news.newswirebiz.com/@viviancreative/creative-biolabs-participates-in-booming-exosome-manufacturing-market-growth-6p3w7mrb535y"></link>
<id>urn:uuid:3a631672-19ea-8c81-0ed8-b3293bb81509</id>
<summary type="html"><![CDATA[Creative Biolabs, a leading life science company specialized in exosome research services, has been one of the top players of growing exosome market size and trend based on its full-scale exosome sampling, analysis, and manufacturing services.]]></summary>
<updated>2022-03-07T09:34:04+00:00</updated>
</entry>
<entry>
<title>Creative Biolabs Girds Exosome Services for Displaying ACE2 Variants</title>
<link href="https://news.newswirebiz.com/@viviancreative/creative-biolabs-girds-exosome-services-for-displaying-ace2-variants-b68qeyq6j8dj"></link>
<id>urn:uuid:65703b61-8337-71ae-af26-d2999e920a79</id>
<summary type="html"><![CDATA[To better aid SARS-CoV-2 drug discovery, Creative Biolabs updates its exosome services for displaying ACE2 variants on the surface of small extracellular vesicles.]]></summary>
<updated>2022-02-18T05:38:24+00:00</updated>
</entry>
</feed>